PFE RSI

What is PFE?

Pfizer was founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York. Initially a specialty chemical business, the company saw its first major success with santonin, an antiparasitic. Its true transformation into a pharmaceutical giant occurred during World War II when it pioneered the deep-tank fermentation process used to mass-produce penicillin, saving countless lives on the front lines.

Today, Pfizer operates as one of the world’s premier biopharmaceutical companies. Its business model centers on high-stakes research and development aimed at discovering and commercializing medicines in areas with significant unmet medical needs. They focus heavily on internal innovation while also aggressively pursuing strategic acquisitions to bolster their drug pipeline.

The product portfolio is incredibly diverse, spanning oncology, immunology, cardiology, and rare diseases. While they became a household name for the Comirnaty vaccine and Paxlovid during the pandemic, their broader lineup includes heavy hitters like Eliquis for stroke prevention, Prevnar for pneumonia, and Vyndaqel for heart failure. The recent $43 billion acquisition of Seagen has significantly deepened their expertise in antibody-drug conjugates, positioning them as a dominant force in modern cancer treatment.

Financially, Pfizer is currently navigating a transitional period. After record-breaking revenues during the peak of the pandemic, the company is managing a sharp decline in COVID-related sales. However, their balance sheet remains robust enough to support a high dividend yield and continued R&D investment. They have also launched an aggressive cost-realization program to streamline operations and improve profit margins.

Looking toward 2026, the strategic outlook is centered on the New Pfizer. By then, the company expects the Seagen integration to be fully realized, contributing significantly to a goal of eight or more potential blockbusters in oncology. They are also working to mitigate the impact of upcoming patent expirations for legacy drugs. You should expect a leaner, more focused organization that relies on a refreshed pipeline of non-COVID respiratory vaccines and next-generation cancer therapies to drive steady shareholder value.

What is RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and magnitude of price changes. Developed by J. Welles Wilder, RSI ranges from 0 to 100 and helps traders identify overbought or oversold conditions in an asset.

For PFE, monitoring the RSI provides valuable insights into potential trend reversals and entry/exit points. When the RSI drops below 30, Pfizer Inc. is typically considered oversold, suggesting the asset may be undervalued. Conversely, an RSI above 70 indicates overbought conditions.

Understanding PFE RSI Signals

• Oversold (RSI below 30): When PFE RSI falls below 30, it suggests the asset may have been sold off excessively and could be due for a bounce. This is often viewed as a potential buying opportunity, though it's important to consider other factors and not rely solely on RSI.
• Overbought (RSI above 70): An RSI above 70 indicates PFE may be overbought, potentially signaling a pullback or consolidation phase. Traders often use this as a signal to take profits or wait for better entry points.
• Divergences: When PFE price makes new highs or lows but RSI doesn't confirm these moves, it can signal weakening momentum and a possible trend reversal.

Daily vs Weekly RSI for PFE

This page displays both daily and weekly RSI for PFE. The daily RSI responds quickly to short-term price movements, making it useful for day traders and swing traders. The weekly RSI provides a broader perspective on momentum trends, helping longer-term investors identify major oversold or overbought conditions.

By analyzing both timeframes together, you can better understand Pfizer Inc.'s momentum at multiple levels and make more informed trading decisions.

Historical RSI Oversold Analysis

Above, we track historical instances when PFE RSI dropped below 30 (oversold territory). Reviewing these past oversold levels helps identify patterns and understand how Pfizer Inc. has historically responded to oversold conditions. Many traders use these historical reference points to gauge potential support levels and timing for entry positions.